david b kaysen executive profile  biography  bloomberg july    pm et biotechnology company overview of sun biopharma inc snapshotpeople  overviewboard memberscommittees executive profile david b kaysen chief executive officer president and director sun biopharma incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background mr david b kaysen also known as dave has been the chief executive officer and president of sun biopharma inc since september   and august  respectively mr kaysen has more than  years of executive management and sales and marketing experience in the medical products and services industry he served as the chief executive officer president and executive director at cogentix medical inc alternative name uroplasty inc from may   to april    mr kaysen served as the president and chief executive officer of allegro biodiesel corporation formerly diametrics medical inc from december   to june   mr kaysen served as president and chief executive officer at advanced duplications services llc from july  to may  mr kaysen served as president and chief executive officer of cimarron medical inc he served as the president and chief executive officer at compex technologies inc formerly rehabilicare inc from march  to april  mr kaysen served in management roles at emeritus corp a producer and marketer of clinical software programs for nursing homes lectecndm corporation a manufacturer and marketer of disposable ecg monitoring and diagnostic electrodes and electrosurgical products surgidyne inc a manufacturer and marketer of specialty medical products related to surgical wound drainage and redline healthcare a marketer and distributor of medical products equipment linens and services to the nursing home industry from  to  he served as vice president of sales and marketing for vdm corporation from  to  he served as an executive vice president for emeritus a company that developed and marketed clinical assessment software for the nursing home industry mr kaysen served as president and chief executive officer of cq acquisition inc previously surgidyne inc now sterion inc from  to  from  to  he served as vice president of marketing for red linexviiib medimart a medical product distributor mr kaysen also served in various general management positions with american hospital supply corporation from october  to march  he serves as a director of interrad medical inc he has been a director of sun biopharma inc since september   he has been a director of american telecare inc since  and prourocare medical inc since september   he served as an independent director of medicalcv inc now known as dalton industries inc since august  he served as director of advanced duplications services llc mr kaysen served as director of compex technologies inc from march  to april  he served as a director of zevex international inc since november  he served as a director at cimarron medical inc he served as a director of surg ii inc formerly surgidyne inc since  he served as a director of diametrics medical inc now allegro biodiesel corporation from december  to june   he graduated with a bachelor of science degree in business administration from the university of minnesota in read full background corporate headquarters  vista boulevardwaconia minnesota united statesphone fax  board members memberships directorinterrad medical incpresentdirectoramerican telecare incpresentdirectorprourocare medical incpresentchief executive officer president and directorsun biopharma inc education bsba university of minnesota other affiliations allegro biodiesel corporationemeritus corpzevex international inccompex technologies incuniversity of minnesotauniversal media group incsurg ii inccogentix medical incamerican telecare incprourocare medical incinterrad medical inccimarron medical inc annual compensation salarytotal annual compensation stocks options exercisable optionsunexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact sun biopharma inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close david kaysen  emeritus corporation  zoominfocom kaysen david b  the wall street transcript david b kaysen david b kaysen is the president and chief executive officer of rehabilicare inc related interviewsdavid b kaysen  rehabilicare inc rehbfebruary  david kaysen  rehabilicare inc rehbdecember   cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsprotecting assets through a rulesbased fundpaula r wieck published july   in investing strategiesbuy managing risk through strict quality standardsjeffrey p cornellmichael s jordan published july   in investing strategiescompanies covered aapl goog sap nsrgy buy identifying emergingmarket and international stocks with a bottomup processrahul sharma published july   in investing strategiescompanies covered  ge asx tsm hdfc lukoy xom tot rdsa ibulhsgfin arclk buy most popular reportsinvesting strategies published july  buy wireless communications  telecom published july  buy investing strategies published july  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsprotecting assets through a rulesbased fundmanaging risk through strict quality standardsidentifying emergingmarket and international stocks with a bottomup process analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google david kaysen  emeritus corporation  zoominfocomdavid b kaysen board dir medical cv inc a publisher of business information since         search business search executive   advanced search   sign in    hints profile of david kaysen   david kaysen   board dir  medical cv inc   david kaysen email  please login   company name  medical cv inc   company website  wwwmedcvinccom   company address   s robert trl inver grove heights mnunited states   david kaysen profile  board dir  medical cv inc   david kaysen biography  david b kaysen one of our directors since august  serves as president chief executive officer and a director of uroplasty inc a developer manufacturer and marketer of products primarily for the treatment of urinary and fecal incontinence and overactive bladder symptoms mr kaysen served as president and chief executive officer of advanced duplication services llc a privately held duplicatorreplicator of cds and dvds from july  to november  from december  through july  mr kaysen served as president chief executive officer and a director of diametrics medical inc a company that develops manufactures and commercializes blood and tissue analysis systems that provide diagnostic results at the point of patient care mr kaysen has more than  years of executive management and sales and marketing experience in the medical products and services industry most recently serving  years as president chief executive officer and a director of rehabilicare inc now compex technologies inc a manufacturer and marketer of home electrotherapy equipment for the physical therapy rehabilitation occupational and sports medicine markets from  to  mr kaysen served as president chief executive officer and a director of surgidyne inc now sterion inc mr kaysen has also held senior management positions in sales and marketing at several medical product and services companies including redline healthcare american hospital supply corporation emeritus corporation and lectecndm corporation mr kaysen currently serves as a director of zevex international inc a publicly held company engaged in the business of designing manufacturing and distributing medical devices   david kaysen colleagues  name title email             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory      �  walkerss research  a publisher of business information since  all rights reserved uroplasty inc david b kaysen a publisher of business information since         search business search executive   advanced search      sign in    hints company name uroplasty inc ticker symbol upi  address  summer st ne minneapolis mn  united states email infousauroplastycom phone  website wwwuroplastycom fax na             summary                   executive details              financial details               board members             stock ownership      subsidiaries business information the groups principal activity is to design develop manufacture and market medical products for the treatment of urinary incontinence and vesicoureteral reflux the groups main product is macroplastiquer implants an injectable soft tissue bulking agent used to treat certain types of stress urinary incontinence sui sui refers to the involuntary loss of urine as a result of activities that increase intraabdominal pressure macroplastique is also used to treat vesicoureteral reflux vur  a condition occurring mostly in children in which urine flows backward from the bladder into the kidney in addition the groups implantable bulking material is also sold for reconstructive and cosmetic plastic surgery applications under the trade name bioplastiquetm the groups international operations are in the netherlands the united kingdom and canada the group markets its products only outside the united states primarily in europe executive information name title email patrick maxwellchmn na mahedi jiwanicfo vp treasurer na susan holmansec coo vp  operations regulatory affairs na larry heinemannvp  sales marketing na marc herregravenvp  manufacturing na   financial information   all figures in    year sales net income         to see complete results subscribe now to see complete results subscribe now click for more executives        financial summary                income statement                  balance sheet                   cash flows                    ratios           for subscribers onlyclick here to subscribe now             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory    nbsp   walkerss research  a publisher of business information since  all rights reserved david kaysen sun biopharma research inc profile  biography  bloomberg feedback david dave kaysen presidentceo sun biopharma research inc career history presidentceo sun biopharma inc present presidentceo sun biopharma inc present presidentceo uroplasty inc  presidentceo advanced duplications services  presidentceo diametrics medical inc  presidentceo rehabilicare inc  presidentceo medical devices inc  show more website wwwsunbiopharmacom corporate information address  southwest th street suite  gainesville fl  united states phone  fax  web url wwwsunbiopharmacom from the web personal information education university of minnesota bachelors degree business administration memberships board memberships sun biopharma inc board member present universal media group inc board member present sun biopharma inc board member present prourocare medical inc board member present zevex intl inc board member present dalton industries inc board member  medicalcv incuts board member  uroplasty inc board member  advanced duplications services board member  diametrics medical inc board member  surg ii inc board member  rehabilicare inc board member  surgidyne inc board member  medical devices inc board member  show more sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data uroplasty announces ceo resignation uroplasty announces ceo resignation david kaysen resignsindependent director rob kill appointed interim ceopreliminary revenue figures for quarter and year ended march   apr    et from uroplasty inc minneapolis april   prnewswire uroplasty inc nasdaq upi a medical device company that develops manufactures and markets innovative products to treat voiding dysfunctions announced today that david b kaysen has tendered his resignation as president chief executive officer and a member of the board of directors effective april    independent director robert c kill has been named interim chief executive officer while the board of directors conducts a search for a permanent ceo james stauner uroplastys chairman stated dave kaysen has served as our president and ceo since may  and has guided the company through the introduction of its industry leading urgent®pc product including successful completion of clinical trials that resulted in a category  cpt code as well as medicare reimbursement for that product in most jurisdictions  dave assumed the ceo role when uroplasty had virtually all of its operations in europe and generated only  million in revenue  he departs with the company generating over  million in annual sales largely fueled by growth in urgent pc sales we truly appreciate all of daves contributions and wish him the best in his future endeavors rob kill who has been a director of uroplasty since  is currently an operating partner with altamont capital partners a private equity firm  prior to joining altamont mr kill was president and chief executive officer of virtual radiologic corporation a provider of technologyenabled outsourced radiology solutions  before virtual radiologic he was president of misys physician systems a developer of electronic medical record and practice management software  mr kill was with baxter healthcare for the first ten years of his career where he held senior leadership roles in operations marketing and sales preliminary fiscal fourth quarter and full year  revenue uroplasty currently anticipates fourth quarter total revenue of approximately  million and total revenue for the  fiscal year ended march  of approximately  million urgent pc sales in the us totaled approximately  million in the fourth fiscal quarter and approximately  million for the full fiscal year an increase of about  percent over full fiscal year  complete results for the just completed fiscal year are expected to be announced during the second half of may  about uroplasty inc uroplasty inc headquartered in minnetonka minnesota with whollyowned subsidiaries in the netherlands and the united kingdom is a global medical company committed to offering transformative treatment options to specialty physicians our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices our focus is the continued commercialization of our urgent® pc neuromodulation system the only fdacleared system that delivers percutaneous tibial nerve stimulation ptns for the officebased treatment of overactive bladder and associated symptoms of urgency frequency and urge incontinence we also offer macroplastique® an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency for more information on the company and its products please visit uroplasty inc at wwwuroplastycom   forwardlooking information this press release contains forwardlooking statements that reflect our best estimates regarding future events and financial performance these forwardlooking statements are subject to risks and uncertainties that could cause actual results to differ materially from our anticipated results we discuss in detail the factors that may affect the achievement of our forwardlooking statements in our annual report on form k filed with the sec in particular we cannot be certain that we will ever achieve sustained profitability that the rate of reimbursement for ptns treatments will be adequate to justify the cost of our product that other medicare carriers or private payers will provide coverage for this treatment or that existing carriers and payers will not change their coverage decisions that the rate of adoption of our products by new customers will continue or that any of the other risks identified in our k will not adversely affect our expectations as described in these forwardlooking statements contact information uroplasty inc evc group medi jiwani vice president cfo and jenifer kirtland investors treasurer   amy phillips media    source uroplasty inc related links httpwwwuroplastycom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more may    et preview uroplasty announces step study year results demonstrate sustained therapeutic effects of percutaneous tibial nerve stimulation mar    et preview uroplasty to present at the th annual roth growth stock conference my news release contains wide tables view fullscreen looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search david b kaysen  minneapolis mn  intelius sign in we found david b kaysen in minneapolis mn david b kaysen intelius found that david b kaysen is a male between  and  years old from minneapolis mn we have connected them to  addresses  phones and  relatives or associates also known as david brookes kaysen get report now age david b kaysen is in his s david has lived in minneapolis mn saint paul mn manhattan ny davids relatives sally chapeau linda kaysen nancy kaysen sean kaysen david b kaysen zodiac signleo gendermale professional status president at uroplasty  inc get report now want to know more about david get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about david or use our people search engine to find others get background check on david b kaysen get a criminal check on david b kaysen get a public record report on david b kaysen get a people search report on david b kaysen david b kaysens contact information known cities lived in find out where david b kaysen has lived as well as david b kaysens phone numbers and email addresses david b kaysen has lived in  states minnesota address for david b kaysen  s r s minneapolis mn has lived in minneapolis mn saint paul mn get full address report phone numbers associated with david b kaysen    minneapolis mn    minneapolis mn    minneapolis mn get full phone report email addresses associated with david b kaysen dncom dnnet dncom get email report david b kaysens education information known schools attended learn about david b kaysens academic history find out which schools david b kaysen attended the dates attended as well as the degrees david b kaysen received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act david b kaysen has attended  schools university of minnesotatwin cities david b kaysen has a bachelor of science business administration in business administration university of minnesotatwin cities david b kaysen has a bachelor of science in business administration david b kaysens professional information information regarding david b kaysens professional history find out previous places david b kaysen has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act david b kaysen has worked at  places company uroplasty  inc title president company uroplasty  inc title board member david b kaysens experience title president company uroplasty  inc job details uroplasty inc headquartered in minnetonka minnesota with whollyowned subsidiaries in the netherlands and the united kingdom is a medical device company that develops manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions our focus is the continued commercialization of our urgent pc neuromodulation system which we believe is the only fdaapproved minimally invasive nerve stimulation device designed for officebased treatment of overactive bladder and the associated symptoms of urinary urgency urinary frequency and urge incontinence we also offer macroplastique® implants an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency title board member company uroplasty  inc job details company size  mil to less than  mil  employee range  to less than  uroplasty inc headquartered in minnetonka minnesota with whollyowned subsidiaries in the netherlands and the united kingdom is a medical device company that develops manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions our focus is the continued commercialization of our urgent pc neuromodulation system which we believe is the only fdaapproved minimally invasive nerve stimulation device designed for officebased treatment of overactive bladder and the associated symptoms of urinary urgency urinary frequency and urge incontinence we also offer macroplastique® implants an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency additional professional information on david b kaysen see david b kaysens linkedin profile david b kaysens social network and potential email matches find out potential social network profiles and potential email usernamed for david b kaysen david b kaysens known social networks and potential email matches find all of david b kaysens social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches david kaysen username matches davidkaysen kaysendavid davidkaysen kaysendavid davidkaysen kaysendavid davidkaysen kaysendavid dkaysen popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches d kaysen intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here